Infection Potential Articles & Analysis
42 news found
Overall, patients need to know that the lower their Ct is the more indicative the result is of heavy infection and potentially, the more infectious they are for those around them. ...
A new generation of vaccines has the potential to better prevent infections and to more broadly show efficacy against future viral variants. ...
“Our evaluation confirmed the great potential for the Orchid SRV and Linear’s platform technology, which is designed to meet a critically important unmet clinical need. ...
The concept is analogous to breakaway devices that help prevent hazardous fuel spills when a customer at a gas station mistakenly drives away with the gas nozzle still in the fuel tank. Potential advantages of the valve include: For nurses: Greater efficiency through avoiding dislodgements and unscheduled IV restarts Less exposure to sharps injuries and ...
The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in vascular see all too often,” said focus group participant Kevin Botelho, RN, BSN, VA-BC, a vascular access specialist at Concord Hospital, in ...
The rationale for this program is based in part on published clinical evidence from Seres’ collaborators at Memorial Sloan Kettering Cancer Center showing that allogeneic HSCT patients with decreased diversity of commensal microbes are significantly more likely to die due to infection and/or lethal GvHD. SER-155 was developed using Seres’ reverse translational ...
“These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” said Matthew Henn, Ph.D., Chief Scientific Officer at Seres. ...
SER-109 is an investigational oral microbiome therapeutic for the prevention of recurrentC. difficile infection (rCDI). With an oral and poster presentation, Seres will present data on how SER-109 restores the functionality of the microbiome in a rapid and durable manner, which further supports the potential of microbiome therapeutics. ...
Lost in the surgical backlog, already delayed diagnoses may be further delayed, potentially lowering patient outcomes. That’s why early detection is crucial; for patients with local to regional prostate cancer (PCa), the 5 year survival rate is nearly 100%, but drops to 30% once the cancer begins to spread to other organs.1 The current standard diagnostic pathway is a PSA ...
The patented RPIDD method is going to revolutionize the traditional first line clinical diagnostics for infectious diseases such as blood culture, PCR (etc), and we are convinced that a rapid molecular liquid biopsy based diagnostics approach for infectious diseases will disrupt the current approaches and hence in due course potentially reduce infected ...
In this trial, we expect to generate data that will highlight the broad therapeutic potential of our lead compound zapnometinib, a dual-effect MEK-inhibitor that is expected to work against all existing variants of SARS-CoV-2. ...
“These new data continue to support the potential for posoleucel to prevent infections caused by these six viruses that can lead to significant morbidity and mortality in a vulnerable patient population with limited to no effective treatment ...
ByKalaris
For patients undergoing peritoneal dialysis (PD), rates of infection-driven hospitalization are as high as 0.5 hospitalizations per patient year, according to the U.S. ...
BenevolentAI scientists then supplemented this with relevant biological context so that the network represented, at a molecular level, how SARS-CoV-2 enters and infects cells, as well as the potentially lethal inflammatory response, the so-called ‘cytokine storm’. ...
CpG 1018 Adjuvanted Shingles (Herpes Zoster) Vaccine Candidate Enters the Clinic Shingles is an extremely painful consequence of the reactivation of a latent varicella zoster virus infection, with attacks leading to potential complications including chronic pain. ...
Treatment of AdV infection is posoleucel’s second potential indication to receive RMAT designation Phase 3 registrational study of posoleucel for AdV treatment is now open for enrollment Proof-of-concept study of ALVR106 for the treatment of multiple respiratory viral infections is also open for enrollment AlloVir, a late-clinical ...
ByKalaris
BlueWillow’s rPA/NE01 anthrax vaccine, BW-1010, developed in collaboration with Porton Biopharma Limited (UK) and funded by the National Institute of Allergy and Infectious Diseases, is an intranasal recombinant protein vaccine candidate against anthrax with proven safety and immunogenicity data in humans that can potentially protect from infection, disease ...
A summary of the abstracts are as follows: The REMOVE (“Revealing Mechanisms and Investigating Efficiency Of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients with Infective Endocarditis“) investigator initiated randomized, controlled trial enrolled 288 patients with documented infective endocarditis with a EuroSCORE II ...
Colonization of AMR pathogens in the gut is a known risk factor for infection and common among people with recurrent CDI. The PUNCH CD3 analysis also showed that RBX2660 treatment responders exhibited reduction in primary bile acids, known to trigger CDI spore germination, and increase secondary bile acids, known to inhibit spore germination and growth.1 About the gut microbiome ...
The application is specified for the indication osteomyelitis (bone infection) and can potentially result in an approval in Q1 of 2022. In February of this year, the FDA requested further data and clarifications on BONESUPPORT’s DeNovo application. ...